FDA panel votes unanimously to make birth control pill available over the counter


The U.S. Food and Drug Administration's advisory panel voted unanimously to make the birth control pill Opill available over the counter, saying that the benefits outweigh the risks, The New York Times reports. "I think Opill has the potential to have a huge positive public health impact," said advisory committee member Kathryn Curtis.
While Opill manufacturer Perrigo called the outcome "groundbreaking," this doesn't mean the pill will be available just yet, CNN writes. The FDA is not required to listen to the advisory committee and will decide whether to make the pill available sometime in the summer. Some agency members are concerned about whether people will use the product as directed, especially those with health conditions and adolescents. "The FDA has been put in a very difficult position of trying to determine whether it is likely that women will use this product safely and effectively at the nonprescription setting," explained Dr. Karen Murry, deputy director of the FDA's office of nonprescription drugs.
The push to approve Opill is stronger than ever as many states have adopted extra-restrictive abortion bans following the overturning of Roe v. Wade (1973). Maternal healthcare has also reportedly been on a decline because of these laws. "I think this represents a landmark in our history of women's health," commented advisor Dr. Marjorie Gass said of the FDA progress. "Unwanted pregnancies can really derail a woman's life, and especially an adolescent's life."
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
"We are motivated by the millions of people who need easy access to safe and effective contraception," remarked Perrigo president and CEO Murray S. Kessler in a statement. "Today's outcome reflects Perrigo's steadfast commitment to women and people, and their health."
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Devika Rao has worked as a staff writer at The Week since 2022, covering science, the environment, climate and business. She previously worked as a policy associate for a nonprofit organization advocating for environmental action from a business perspective.
-
Book reviews: 'America, América: A New History of the New World' and 'Sister, Sinner: The Miraculous Life and Mysterious Disappearance of Aimee Semple McPherson'
Feature A historian tells a new story of the Americas and the forgotten story of a pioneering preacher
-
Another messaging app used by the White House is in hot water
The Explainer TeleMessage was seen being used by former National Security Adviser Mike Waltz
-
AI hallucinations are getting worse
In the Spotlight And no one knows why it is happening
-
Fly like a breeze with these 5 tips to help cope with air travel anxiety
The Week Recommends You can soothe your nervousness about flying before boarding the plane
-
RFK Jr.'s focus on autism draws the ire of researchers
In the Spotlight Many of Kennedy's assertions have been condemned by experts and advocates
-
Hantavirus: the rare pathogen linked to rodents that attacks the lungs
The Explainer Despite the low risk of contracting it, the virus could be potentially deadly
-
Full-body scans: are Neko Health and the like more panic than panacea?
The Explainer Hailed as the 'future of medicine' by some, but not all experts are convinced
-
Fighting against fluoride
Feature A growing number of communities are ending water fluoridation. Will public health suffer?
-
RFK Jr. visits Texas as 2nd child dies from measles
Speed Read An outbreak of the vaccine-preventable disease continues to grow following a decade of no recorded US measles deaths
-
What does Health and Human Services do?
The Explainer Cuts will 'dramatically alter' public health in America
-
Shingles vaccine cuts dementia risk, study finds
Speed Read Getting vaccinated appears to significantly reduce the chances of developing Alzheimer's and other forms of dementia